GS
FLNA

Gagnon Securities’s Filana Therapeutics FLNA Stock Holding History

Gagnon Securities’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,568
Closed -$63K – 94
2017
Q3 		$63K Hold
15,568
– – 0.02% 90
2017
Q2 		$65 Buy
15,568
+8,813
+130% +$41.6K 0.02% 84
2017
Q1 		$42K Buy
6,755
+245
+4% +$1.11K 0.02% 92
2016
Q4 		$26K Sell
6,510
-3,414
-34% -$15.8K 0.01% 94
2016
Q3 		$69K Hold
9,924
– – 0.03% 94
2016
Q2 		$152K Sell
9,924
-75
-0.8% -$1.19K 0.07% 83
2016
Q1 		$156K Buy
9,999
+1,028
+11% +$13.3K 0.07% 77
2015
Q4 		$110K Hold
8,971
– – 0.05% 77
2015
Q3 		$115K Hold
8,971
– – 0.06% 78
2015
Q2 		$109K Sell
8,971
-31
-0.3% -$425 0.04% 83
2015
Q1 		$119K Hold
9,002
– – 0.04% 85
2014
Q4 		$128K Buy
9,002
+90
+1% +$1.56K 0.04% 89
2014
Q3 		$244K Buy
8,912
+80
+0.9% +$2.43K 0.08% 78
2014
Q2 		$355K Sell
8,832
-1,221
-12% -$45.2K 0.11% 66
2014
Q1 		$387K Buy
10,053
+86
+0.9% +$3.04K 0.12% 68
2013
Q4 		$339K Buy
9,967
+635
+7% +$16.9K 0.1% 67
2013
Q3 		$178K Buy
+9,332
New +$163K 0.06% 81

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gagnon Securities's FLNA Position: Q4 2017 in Review

Gagnon Securities sold out of Filana Therapeutics (FLNA) in Q4 2017, closing a stake of 15,568 shares — an estimated $63K sold.

Gagnon Securities first reported a position in FLNA in Q3 2013 and held it in 17 quarters. The position peaked at $387K in Q1 2014. 26 funds tracked by Wall St. Rank hold FLNA as of Q4 2017.

  • Gagnon Securities reported no remaining Filana Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Gagnon Securities sold 15,568 Filana Therapeutics shares in Q4 2017, an estimated $63K.
  • Gagnon Securities first reported a position in Filana Therapeutics in Q3 2013 and held it in 17 quarters.
  • Gagnon Securities's Filana Therapeutics position peaked at $387K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2017.

Based on Gagnon Securities's 13F filing for Q4 2017, filed 13 Feb 2018.